Abstract
A phase III trial of the agent MDV3100 in men with advanced prostate cancer previously treated with docetaxel-based chemotherapy is being stopped early so that the drug can be given to all participants.
MeSH terms
-
Benzamides
-
Clinical Trials, Phase III as Topic
-
Humans
-
Male
-
Nitriles
-
Phenylthiohydantoin / analogs & derivatives*
-
Phenylthiohydantoin / therapeutic use
-
Prostatic Neoplasms / drug therapy*
-
Survival Rate
Substances
-
Benzamides
-
Nitriles
-
Phenylthiohydantoin
-
enzalutamide